2021 annual financial data

Autolus Therapeutics 2021 Operating cash flow margin

Direct answer

Operating cash flow margin was -7,820.9%.

Operating income was -140.37M USD and net income was -142.1M USD.
Operating cash flow was -117.86M USD.

Get free Autolus Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1.51M USD
Operating income
-140.37M USD
Net income
-142.1M USD
Operating cash flow
-117.86M USD